264 related articles for article (PubMed ID: 33274828)
1. An assay for cancer stem cell-induced angiogenesis on chick chorioallantoic membrane.
Nawara HM; Afify SM; Hassan G; Zahra MH; Atallah MN; Seno A; Seno M
Cell Biol Int; 2021 Apr; 45(4):749-756. PubMed ID: 33274828
[TBL] [Abstract][Full Text] [Related]
2. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
Sun H; Jia J; Wang X; Ma B; Di L; Song G; Ren J
Clin Transl Oncol; 2013 Jan; 15(1):46-54. PubMed ID: 22855175
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic activity of zinc and zinc-sorafenib combination using the chick chorioallantoic membrane assay: A descriptive study.
Kumar M; Meshram GG; Rastogi T; Sharma S; Gupta R; Jain S; Prasad A; Galav V; Bhattacharya SK
J Cancer Res Ther; 2020 Dec; 16(Supplement):S84-S89. PubMed ID: 33380658
[TBL] [Abstract][Full Text] [Related]
4. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
[TBL] [Abstract][Full Text] [Related]
5. The Chick Chorioallantoic Membrane Model: A New In Vivo Tool to Evaluate Breast Cancer Stem Cell Activity.
Pinto MT; Ribeiro AS; Conde I; Carvalho R; Paredes J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396951
[TBL] [Abstract][Full Text] [Related]
6. Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.
Kennedy DC; Coen B; Wheatley AM; McCullagh KJA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008876
[TBL] [Abstract][Full Text] [Related]
7. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
8. Methods for Analyzing Tumor Angiogenesis in the Chick Chorioallantoic Membrane Model.
Ames JJ; Henderson T; Liaw L; Brooks PC
Methods Mol Biol; 2016; 1406():255-69. PubMed ID: 26820962
[TBL] [Abstract][Full Text] [Related]
9. Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids.
Laborda-Illanes A; Sánchez-Alcoholado L; Castellano-Castillo D; Boutriq S; Plaza-Andrades I; Aranega-Martín L; Peralta-Linero J; Alba E; González-González A; Queipo-Ortuño MI
Biomed Pharmacother; 2023 Jan; 157():114041. PubMed ID: 36423543
[TBL] [Abstract][Full Text] [Related]
10. The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma.
Ribatti D; Tamma R
J Cell Physiol; 2018 Jan; 234(1):152-157. PubMed ID: 30078179
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal bioluminescence imaging to monitor breast tumor growth and treatment response using the chick chorioallantoic membrane model.
Javed S; Soukhtehzari S; Fernandes N; Williams KC
Sci Rep; 2022 Oct; 12(1):17192. PubMed ID: 36229503
[TBL] [Abstract][Full Text] [Related]
12. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
Tufan AC; Satiroglu-Tufan NL
Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
14. The chick embryo chorioallantoic membrane as an experimental model to study in vivo angiogenesis in glioblastoma multiforme.
Ribatti D
Brain Res Bull; 2022 May; 182():26-29. PubMed ID: 35143927
[TBL] [Abstract][Full Text] [Related]
15. Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules.
Deryugina EI; Quigley JP
Methods Enzymol; 2008; 444():21-41. PubMed ID: 19007659
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic activity of gecko aqueous extracts and its macromolecular components in CAM and HUVE-12 cells.
Tang Z; Huang SQ; Liu JT; Jiang GX; Wang CM
Asian Pac J Cancer Prev; 2015; 16(5):2081-6. PubMed ID: 25773854
[TBL] [Abstract][Full Text] [Related]
17. The chick embryo chorioallantoic membrane as a model for tumor biology.
Ribatti D
Exp Cell Res; 2014 Nov; 328(2):314-24. PubMed ID: 24972385
[TBL] [Abstract][Full Text] [Related]
18. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
Ribatti D
Rom J Morphol Embryol; 2008; 49(2):131-5. PubMed ID: 18516317
[TBL] [Abstract][Full Text] [Related]
19. The CAM assay in the study of the metastatic process.
Ribatti D
Exp Cell Res; 2021 Mar; 400(2):112510. PubMed ID: 33524363
[TBL] [Abstract][Full Text] [Related]
20. The chick embryo chorioallantoic membrane (CAM) assay.
Ribatti D
Reprod Toxicol; 2017 Jun; 70():97-101. PubMed ID: 27832950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]